Solas Capital Management, LLC - PROCESSA PHARMACEUTICALS INC ownership

PROCESSA PHARMACEUTICALS INC's ticker is PCSA and the CUSIP is 74275C205. A total of 19 filers reported holding PROCESSA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Solas Capital Management, LLC ownership history of PROCESSA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$69,000
-92.8%
22,844
-88.4%
0.04%
-93.9%
Q4 2021$961,000
-42.8%
196,1500.0%0.68%
-41.5%
Q3 2021$1,681,000
+4.7%
196,1500.0%1.17%
+3.8%
Q2 2021$1,606,000
-26.3%
196,150
-1.9%
1.13%
-38.5%
Q1 2021$2,180,000
-26.5%
200,000
-55.6%
1.83%
-19.0%
Q4 2020$2,968,000450,0002.26%
Other shareholders
PROCESSA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Coastal Bridge Advisors, LLC 52,500$13,1360.00%
Mirador Capital Partners LP 19,516$4,8830.00%
WELLS FARGO & COMPANY/MN 3,238$8100.00%
NORTHERN TRUST CORP 15,401$3,8530.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 152,670$38,9300.00%
STATE STREET CORP 42,786$10,9100.00%
MILLENNIUM MANAGEMENT LLC 25,930$6,6120.00%
BlackRock Inc. 293$730.00%
Citadel Advisors 166,224$42,3870.00%
View complete list of PROCESSA PHARMACEUTICALS INC shareholders